---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "GWGYQUajDUVLgP22NLlvxbc8td8KMHj1YqwnFWDn7+7/YiK0u7Xb1jt7oNnDmapInX7TtY4u4xs/osDMnRUWA0ePW+i4e6eC6XmpuK+57CoZWNprPmnPpFIEkBtT2RrGpSWOuj1gKHQl9srb6LwU47P9Cevs8PRE9mXklxITskrfH1NnRtU0r2HCahn7PhV8PGfZbTQzTUXqRZ7GkYE76FRrI0Qw5KgiQyiBaF1pj3Vbxkxc9Gt/z0lZhIVzjHK70TolU3eCVR5Jbz7diDyGTS9SaB5viv5l91PCKaFCLBut+j9mRqsnQ3oG1UaKFJ0p;GIBxMw+HhLIv5kVNCiEdtw=="
---

